Today’s top gainers include the company Abbott Laboratories (NYSE:ABT) which is in the industry Medical Appliances & Equipment, gaining -0.27% today. In the last week its performance is 3.00%, and 6.98% for the past quarter. Currently, Abbott Laboratories, ABT has a target price of 48.25, so today’s gain of -0.27% is a significant step towards its target price. The GAP today is therefore -0.27%.
Abbott Laboratories (NYSE:ABT), has a market cap of 83.22 B, and is based in USA. Insider ownership is at 0.70%, and institutional ownership is 73.50%.
At the current price of 47.99, it has a dividend yield of 2.20%, and its target price is 48.25. This is with a profit margin of 6.70%, and total debt/equity of 0.76. Abbott Laboratories (NYSE:ABT) has a P/E of 53.41, as well as a forward P/E of 17.46.
With a current EPS of 0.9, and a forecasted EPS growth for next year at 11.67%,Abbott Laboratories (NYSE:ABT) has had a EPS growth for the past five years at 0.00%. For the next five years EPS growth is projected to be 11.22%.
Performance for the year is 28.56%. Since its IPO date on 04/06/1983, the total performance to date is 25.28%.
Volume today for Abbott Laboratories (NYSE:ABT), is 304, while its average volume is 6537.72. Whilst the total gain today was -0.27%, it did have a day high of -0.72%.
Volatility for this week has been at 1.44%, and 1.33% for the month. The 52-week low for Abbott Laboratories, ABT has been 30.55%, while the 52-week-high has reached -0.72%.
Looking at its return of investments, which is 6.70%, and its return on assets is 3.00%. Abbott Laboratories (NYSE:ABT) has an operating margin of 11.00%. With a sales growth of 29.70% quarter over quarter. Bearing in mind that Abbott Laboratories, ABT is in the sector Healthcare, its long-term debt/equity is 0.76, and has a current ratio of 2.9 and 2.3 for quick ratio.
So what is the value of Abbott Laboratories? Well its PEG is 4.76, and the P/S is 3.73, along with a P/B of 2.65. Meanwhile it has a p/cash of 9.39.